Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia

NCT06581081 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Adult ALL
B-cell Acute Lymphoblastic Leukemia
Refractory Acute Lymphoblastic Leukemia
Relapsed Pediatric ALL

Interventions

BIOLOGICAL: Senl_B19 autologous CAR-T (S1904) treatment

Sponsor

Peking University People's Hospital

Collaborators

[object Object]
[object Object]